Oligonucleotide (oligo) therapies have been in development for decades. Recent advances in molecular design, chemistry, ...
Combined clearance of the navigation and drug delivery technologies enables Canadian neurosurgery centers to leverage the Company's flagship image-guidance workflow and advances ClearPoint Neuro's ...
A Goldman Sachs veteran says this platform would have funded faster as a rectal drug. Merck disagreed. Here's what took so ...
SOLANA BEACH, CA / ACCESS Newswire / April 22, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) ("Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brai ...
Explore the economic and logistical factors driving prescription drug shortages and their impact on global patient care.
Severe drug shortages in Nigeria's primary healthcare centers are putting millions at risk. Experts warn of preventable ...
Drug delivery has undergone a remarkable transformation from basic oral tablets to sophisticated, targeted systems that deliver treatments with unprecedented precision. Today's pharmaceutical ...
Instead of applying ointment and attaching a bandage, a "smart patch that regulates treatment intensity on its own just by ...
Bombay High Court rules that drug variants not listed in NLEM are exempt from price caps under DPCO 2013, offering relief to ...
Bombay High Court rules that drug variants not listed in NLEM are exempt from price caps under DPCO 2013, offering relief to pharma firms but raising concerns over regulatory loopholes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results